(Q44198467)

30 November 2017

Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study (English)

1 reference

chronic obstructive pulmonary disease

30 November 2017

0 references

author

Job van der Palen

series ordinal

3

1 reference

30 November 2017

4

Gerhard Zielhuis

1 reference

30 November 2017

Paul van der Valk

1

1 reference

30 November 2017

Evelyn Monninkhof

series ordinal

2

1 reference

30 November 2017

Cees van Herwaarden

series ordinal

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

5 September 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

30 November 2017

1 reference

30 November 2017

166

1 reference

30 November 2017

1358-1363

1 reference

30 November 2017

10

1 reference

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

30 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

New therapies for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Issues concerning health-related quality of life in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-512OC

10.1164/RCCM.200206-512OC

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference